Identification of Sarcopenia Components That Discriminate Slow Walking Speed: A Pooled Data Analysis.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
07 2020
Historique:
received: 30 10 2019
revised: 20 02 2020
accepted: 18 03 2020
pubmed: 8 7 2020
medline: 26 2 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

The Sarcopenia Definitions and Outcomes Consortium (SDOC) sought to identify cut points for muscle strength and body composition measures derived from dual-energy x-ray absorptiometry (DXA) that discriminate older adults with slow walking speed. This article presents the core analyses used to guide the SDOC position statements. Cross-sectional data analyses of pooled data. University-based research assessment centers. Community-dwelling men (n = 13,652) and women: (n = 5,115) with information on lean mass by DXA, grip strength (GR), and walking speed. Thirty-five candidate sarcopenia variables were entered into sex-stratified classification and regression tree (CART) models to agnostically choose variables and cut points that discriminate slow walkers (<0.80 m/s). Models with alternative walking speed outcomes were also evaluated (<0.60 and <1.0 m/s and walking speed treated continuously). CART models identified GR/body mass index (GRBMI) and GR/total body fat (GRTBF) as the primary discriminating variables for slowness in men and women, respectively. Men with GRBMI of 1.05 kg/kg/m GR with and without adjustments for body size and composition consistently discriminated older adults with slowness. CART models did not select DXA-based lean mass as a primary discriminator of slowness. These results were presented to an SDOC Consensus Panel, who used them and other information to develop the SDOC Position Statements. J Am Geriatr Soc 68:1419-1428, 2020.

Sections du résumé

BACKGROUND
The Sarcopenia Definitions and Outcomes Consortium (SDOC) sought to identify cut points for muscle strength and body composition measures derived from dual-energy x-ray absorptiometry (DXA) that discriminate older adults with slow walking speed. This article presents the core analyses used to guide the SDOC position statements.
DESIGN
Cross-sectional data analyses of pooled data.
SETTING
University-based research assessment centers.
PARTICIPANTS
Community-dwelling men (n = 13,652) and women: (n = 5,115) with information on lean mass by DXA, grip strength (GR), and walking speed.
MEASUREMENTS
Thirty-five candidate sarcopenia variables were entered into sex-stratified classification and regression tree (CART) models to agnostically choose variables and cut points that discriminate slow walkers (<0.80 m/s). Models with alternative walking speed outcomes were also evaluated (<0.60 and <1.0 m/s and walking speed treated continuously).
RESULTS
CART models identified GR/body mass index (GRBMI) and GR/total body fat (GRTBF) as the primary discriminating variables for slowness in men and women, respectively. Men with GRBMI of 1.05 kg/kg/m
CONCLUSION
GR with and without adjustments for body size and composition consistently discriminated older adults with slowness. CART models did not select DXA-based lean mass as a primary discriminator of slowness. These results were presented to an SDOC Consensus Panel, who used them and other information to develop the SDOC Position Statements. J Am Geriatr Soc 68:1419-1428, 2020.

Identifiants

pubmed: 32633834
doi: 10.1111/jgs.16524
pmc: PMC8018524
mid: NIHMS1614576
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1419-1428

Subventions

Organisme : NIA NIH HHS
ID : P30 AG024827
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG031679
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028747
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG051421
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG061085
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The American Geriatrics Society.

Références

J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
pubmed: 10811152
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1317-1323
pubmed: 30869772
Epidemiol Rev. 2013;35:51-65
pubmed: 23221972
J Geriatr Phys Ther. 2009;32(2):46-9
pubmed: 20039582
J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):935-40
pubmed: 26519945
J Rehabil Res Dev. 2005 Jul-Aug;42(4):535-46
pubmed: 16320148
Curr Opin Clin Nutr Metab Care. 2013 Jan;16(1):21-6
pubmed: 23222705
J Gerontol A Biol Sci Med Sci. 2005 Jan;60(1):74-9
pubmed: 15741286
J Bone Metab. 2013 May;20(1):1-10
pubmed: 24524049
J Am Geriatr Soc. 2020 Jul;68(7):1410-1418
pubmed: 32150289
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
J Am Med Dir Assoc. 2015 Mar;16(3):247-52
pubmed: 25548028
Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3
pubmed: 2520314
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):14-21
pubmed: 30900400
Semin Nucl Med. 1997 Jul;27(3):210-28
pubmed: 9224663
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):253-9
pubmed: 25425503
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):584-90
pubmed: 24737561
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58
pubmed: 24737557
J Am Geriatr Soc. 2005 Oct;53(10):1675-80
pubmed: 16181165
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
J Gerontol A Biol Sci Med Sci. 2019 May 16;74(6):844-852
pubmed: 29897420
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Am J Prev Med. 2017 Jul;53(1):63-69
pubmed: 28190692
JAMA. 2014 May;311(20):2061-2
pubmed: 24763978
JAMA. 2011 Jan 5;305(1):50-8
pubmed: 21205966
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
J Aging Phys Act. 2015 Apr;23(2):314-22
pubmed: 24812254
EJIFCC. 2009 Jan 20;19(4):203-11
pubmed: 27683318
J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1269-1271
pubmed: 30680964
J Am Geriatr Soc. 2020 Jul;68(7):1429-1437
pubmed: 32633824
J Gerontol A Biol Sci Med Sci. 2012 Jan;67(1):28-40
pubmed: 21444359

Auteurs

Todd M Manini (TM)

Department of Aging and Geriatric Research, University of Florida, Gainesville, Florida, USA.

Sheena M Patel (SM)

California Pacific Medical Research Institute, San Francisco, California, USA.

Anne B Newman (AB)

Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Thomas G Travison (TG)

Department of Medicine, Harvard Medical School and Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.

Douglas P Kiel (DP)

Department of Medicine, Harvard Medical School and Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.

Michelle D Shardell (MD)

Institute for Genomes Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Karol M Pencina (KM)

Department of Medicine, Harvard Medical School and Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.

Kevin E Wilson (KE)

Hologic, Inc, Marlborough, Massachusetts, USA.

Thomas L Kelly (TL)

Hologic, Inc, Marlborough, Massachusetts, USA.

Joseph M Massaro (JM)

Department of Biostatistics, Boston University, Boston, Massachusetts, USA.

Roger A Fielding (RA)

Tufts University, Boston, Massachusetts, USA.

Jay Magaziner (J)

Department of Epidemiology, University of Maryland Baltimore, Baltimore, Maryland, USA.

Rosaly Correa-de-Araujo (R)

Division of Geriatrics and Clinical Gerontology, US Department of Health and Human Services, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.

Timothy C Y Kwok (TCY)

The Chinese University, Hong Kong Special Administrative Region, China.

Vasant Hirani (V)

University of Sydney, Sydney, New South Wales, Australia.

Magnus K Karlsson (MK)

Lund University, Skane University Hospital, Malmo, Sweden.

Ralph B DʼAgostino (RB)

Boston University, Boston, Massachusetts, USA.

Dan Mellström (D)

University of Gothenburg, Gothenburg, Sweden.

Claes Ohlsson (C)

University of Gothenburg, Gothenburg, Sweden.

Eva Ribom (E)

Uppsala University, Uppsala, Sweden.

Joanne M Jordan (JM)

University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Shalender Bhasin (S)

Department of Medicine, Harvard Medical School and Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.

Peggy M Cawthon (PM)

California Pacific Medical Research Institute, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH